Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07850310 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)

Name: A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001) — clinical trial record (NCT07850310)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorMerck Sharp & Dohme LLC

Started2026-10-06

View on ClinicalTrials.gov ↗

Merck (MSD)

401 trials monitored

See 24 trials at risk

Psoriasis

418 trials monitored

See 17 trials at risk

The purpose of this trial is to learn about a trial medicine called MK-8644. This trial is the first time researchers will give MK-8644 to people. This trial will help researchers learn about the safety of MK-8644 and if participants tolerate it. Tolerate means participants will receive MK-8644 in the trial unless they need to stop it due to health problems.

Trial Details

NCT Number	NCT07850310
Lead Sponsor	Merck Sharp & Dohme LLC
Conditions	Psoriasis, Healthy
Enrollment	132 participants
Start Date	2026-10-06
Primary Completion	2027-12-13 (estimated)
Study Completion	2027-12-13 (estimated)
Updated on ClinicalTrials.gov	2026-09-30